Clin2
NCT06977035Possibly a fitRecruiting

Nerve study for arthritis patients on baricitinib

Rheumatoid Arthritis

Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.

This trial checks how the medication baricitinib affects nerves in people with rheumatoid arthritis. It uses a nerve test to see if the drug causes nerve problems.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have rheumatoid arthritis diagnosed by your doctor.
  • You are between 18 and 65 years old.
  • You can cooperate and answer questions during the study.
  • You do not have other joint or connective tissue diseases.
  • You do not have other causes of nerve damage, such as diabetes.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07357649Not yet recruiting· Phase 4
Study of baricitinib on blood clotting in rheumatoid arthritis

This trial tests if baricitinib, a medication for rheumatoid arthritis, can improve blood clotting issues that some patients with active RA face. It is for adults whose RA is not well-controlled by standard treatments.

Tanta
NCT05955066Recruiting· Phase 4
Testing a JAK inhibitor to help RA joint erosion heal

This Phase 4 study tests whether a JAK inhibitor (baricitinib) can improve how RA-related bone erosion heals. You might be eligible if you have rheumatoid arthritis that is still active despite methotrexate treatment, and you meet the specific safety and medication history rules.

Hong Kong, Hong Kong
NCT05003310Recruiting
Splenic stimulation study for active rheumatoid arthritis

This study tests a treatment that stimulates the spleen to help calm symptoms of active rheumatoid arthritis (RA). It’s mainly for people whose RA has not improved enough after several newer arthritis medicines.

Anniston, Alabama
NCT06567470Recruiting· Phase 2
Study of CIT-013 for rheumatoid arthritis

This trial tests a new medicine called CIT-013 for people with rheumatoid arthritis. It aims to see if CIT-013 can help reduce joint swelling and pain when added to your current treatment.

Antwerp
NCT07491016Recruiting
Telitacicept plus baricitinib for hard-to-treat rheumatoid arthritis

This study tests a combination of two drugs (telitacicept and baricitinib) for people with stubborn rheumatoid arthritis that hasn't improved with other treatments. The goal is to see if this combination is safe and effective in reducing joint pain and inflammation.

Hangzhou, Zhejiang
NCT06337786Recruiting
RheumaBuddy app study for rheumatoid arthritis

This study tests if a digital app called RheumaBuddy4.1 can help manage rheumatoid arthritis symptoms. You would use the app at home and report how you feel.

Frederiksberg, Copenhagen F

Hear when a new Rheumatoid arthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.